Full video transcriptClick to expand
Auto-generated transcript of @popethecoach's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00TRT update week 31.
- 0:02And there's been a few changes.
- 0:04Alright, so some of y'all may remember, for the past 6 months, 7 months, however long
- 0:09I've been on TRT, I have pinned continuously left dilt, right dilt, nothing else.
- 0:15That was until I got with the new clinic that I'm with and switched to the new protocol
- 0:19that I'm on.
- 0:20So previously I was only pinning twice a week, 100 on Monday, 100 on Thursday and I was using
- 0:25a 25 gauge one inch.
- 0:27Not too comfy if you ask most people.
- 0:30Now I switched my pinning from 2 times a week to 3 times a week and instead of 200 in total
- 0:35a week, I'm on 150 in total a week, which is 50 on Monday, 50 on Wednesday, 50 on Friday.
- 0:40And the biggest change that I have made that has made a huge difference to me that I've
- 0:44noticed so far is I am now using a 27 gauge half inch and I use it intramuscular in the
- 0:50glute.
- 0:51If y'all don't know what that is, that should be on.
- 0:53The tiredness and fatigue that I was having along with the irritability that I was getting
- 0:57at the higher dosage along with those longer span periods was complete game changer for
- 1:02me.
- 1:03So yes, I'm so on intramuscular just going in a different route and also making sure to
- 1:07use a different gauge because that helps out with the pain level.
- 1:11So thanks for starting to look up now for our TRT journey and again, I'm not an expert.
- 1:15So if you have any tips for other people, leave them over in the comments, save this
- 1:18video, make sure you like it and if you need help with the TRT clinic that I switched to feel
- 1:22free to DM me comment, TRT drop a follow and I'll catch up with y'all later.
- 1:26Doses.
TRT 'best it's been': what the science says about testosterone optimization claims
Quick answer
The creator switched from 200mg testosterone cypionate weekly in two injections to 150mg weekly in three injections, citing reduced fatigue and irritability. This reflects a clinically recognized strategy: more frequent, smaller doses of testosterone cypionate reduce peak-to-trough serum level variability, which can reduce estradiol-related and androgen-fluctuation side effects. The needle change from 25-gauge one-inch to 27-gauge half-inch into the glute represents a shift toward reduced injection-site trauma, though at half an inch in the glute, delivery may be subcutaneous rather than intramuscular depending on body composition.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 7 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For TRT 'best it's been': what the science says about testosterone optimization claims, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
NAD+ metabolism and its roles in cellular processes during ageing
Core review for NAD+ decline, mitochondrial function, DNA repair, and aging biology.
PubMed
Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women
Human NMN source for metabolic claims while keeping population limits clear.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
TRT 'best it's been': what the science says about testosterone optimization claims is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "TRT 'best it's been': what the science says about testosterone optimization claims" from Pope | The Coach. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The creator switched from 200mg testosterone cypionate weekly in two injections to 150mg weekly in three injections, citing reduced fatigue and irritability.
The reason this review is not generic is the source wording and the canonical claim label "trt this is the best it has been since we have started fyp trt t." In this clip, the useful excerpt is: "TRT update week 31." That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.
The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
The creator switched from 200mg testosterone cypionate weekly in two injections to 150mg weekly in three injections, citing reduced fatigue and irritability.
FormBlends verdict
Testosterone evidence, safety, and patient-fit context
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- The creator switched from 200mg testosterone cypionate weekly in two injections to 150mg weekly in three injections, citing reduced fatigue and irritability. This reflects a clinically recognized strategy: more frequent, smaller doses of testosterone cypionate reduce peak-to-trough serum level variability, which can reduce estradiol-related and androgen-fluctuation side effects. The needle change from 25-gauge one-inch to 27-gauge half-inch into the glute represents a shift toward reduced injection-site trauma, though at half an inch in the glute, delivery may be subcutaneous rather than intramuscular depending on body composition.
- More frequent testosterone injections at lower per-dose amounts reduce peak-to-trough serum variability, which is the likely mechanism behind his symptom improvement, per Ramasamy et al. (2017, Journal of Urology).
- 150mg of testosterone cypionate weekly is within the range many providers use for hypogonadism, but the right dose is determined by labs and symptoms, not by copying someone else's protocol.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- More frequent testosterone injections at lower per-dose amounts reduce peak-to-trough serum variability, which is the likely mechanism behind his symptom improvement, per Ramasamy et al. (2017, Journal of Urology).
- 150mg of testosterone cypionate weekly is within the range many providers use for hypogonadism, but the right dose is determined by labs and symptoms, not by copying someone else's protocol.
- A 27-gauge needle has a narrower bore than a 25-gauge, producing less tissue trauma and less injection pain. This is basic needle mechanics, not a trick.
- A half-inch needle in the glute may deliver testosterone subcutaneously rather than intramuscularly depending on body fat. Subcutaneous delivery is not inferior, but calling it IM may be inaccurate.
- Subcutaneous testosterone cypionate injections produce serum levels comparable to intramuscular delivery in hypogonadal men, per Spratt et al. (2021, Journal of the Endocrine Society).
- The Endocrine Society guidelines (Bhasin et al., 2018) recommend targeting mid-normal physiologic testosterone, not peak levels. Supratherapeutic dosing raises estradiol and hematocrit risks.
- The clinic referral via DM at the end of this video represents a commercial interest. That does not make everything he said wrong, but it should inform how you weight his enthusiasm for the new protocol.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @popethecoach actually say?
After 31 weeks on TRT, the creator switched clinics and overhauled his protocol. He dropped from 200mg weekly (100mg twice weekly) down to 150mg weekly (50mg three times weekly) and swapped his injection method from a 25-gauge, one-inch needle to a 27-gauge, half-inch needle in the glute. He credits these changes for reducing the tiredness, fatigue, and irritability he was experiencing on the old protocol. He is clear that he is not an expert and openly invites tips from viewers.
To his credit, he is transparent about the numbers, acknowledges side effects he experienced, and repeatedly disclaims expertise. He is also, at the end of the video, directing people to a specific TRT clinic via DM, which raises a commercial interest worth noting when evaluating his enthusiasm.
Does the science back this up?
Yes, more frequent dosing at a lower total weekly dose is clinically defensible. The fatigue and irritability he described are consistent with what happens when testosterone peaks and troughs are exaggerated by less frequent injections.
Research consistently shows that injection frequency affects the amplitude of testosterone fluctuations. A 2017 study by Ramasamy et al. in the Journal of Urology demonstrated that more frequent, smaller doses produce more stable serum testosterone levels compared to less frequent larger doses. Stable levels matter because supraphysiologic peaks are associated with elevated estradiol, hematocrit changes, and mood volatility, while troughs can produce fatigue and low libido. Switching from twice to three times weekly directly addresses this instability.
The gauge change is also grounded in basic physiology. A 27-gauge needle has a narrower bore than a 25-gauge, which reduces tissue trauma and post-injection pain. The half-inch length is appropriate for subcutaneous or shallow intramuscular injection in the glute, particularly in individuals with lower body fat. The creator seems to be doing intramuscular, which at half an inch in the glute is on the shallow end but generally acceptable depending on body composition.
What did they get wrong (or right)?
He got the core pharmacology right, even if he does not frame it that way. Fewer milligrams delivered more frequently equals less hormonal swing. That is the actual mechanism behind why he feels better, and he deserves credit for recognizing it experientially.
What is less clear is his needle depth claim. A half-inch needle in the glute for true intramuscular injection works for leaner individuals, but for others it may result in subcutaneous delivery. That is not necessarily a problem, as subcutaneous testosterone injections are a legitimate and increasingly studied route. A 2021 paper by Spratt et al. in the Journal of the Endocrine Society found subcutaneous testosterone cypionate produced stable levels comparable to IM in hypogonadal men. But calling it intramuscular when it may be subcutaneous is imprecise.
His total weekly dose drop from 200mg to 150mg is notable. That is a 25 percent reduction. He attributes symptom improvement partly to this lower dose, which is plausible since supraphysiologic testosterone elevates aromatization to estradiol, which is linked to mood effects and fatigue in some men.
What should you actually know?
If you are on TRT and experiencing mood swings, fatigue near injection days, or irritability, the first conversation worth having with your prescribing provider is about injection frequency, not just total dose. The half-life of testosterone cypionate is approximately 8 days, but serum levels fluctuate meaningfully within a week on a twice-weekly schedule for some people.
The 150mg per week dose he is now on falls within what many endocrinologists consider a reasonable therapeutic range for hypogonadism, though dosing is individualized based on labs, symptoms, and response. The Endocrine Society clinical practice guidelines (Bhasin et al., 2018, Journal of Clinical Endocrinology and Metabolism) recommend targeting mid-normal physiologic testosterone levels, not maximum levels.
One thing worth flagging: the creator is directing viewers to DM him for a referral to his new TRT clinic. That is a commercial relationship, not a neutral recommendation. Evaluate that with appropriate skepticism. A good TRT provider will not need a social media referral pipeline.
Bottom line
This video is more accurate than most TRT content on TikTok. The creator is describing a real pharmacological principle, injecting more frequently at lower doses reduces serum level swings and can reduce side effects, without overclaiming it as a cure or pushing supplements. The needle gauge point is accurate. The injection depth nuance is glossed over. The clinic referral at the end warrants transparency he does not fully provide. Overall, this is a reasonably honest personal account, not a medical protocol you should copy without labs and a licensed provider involved.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Pope | The Coach · TikTok creator
61.1K views on this video
This is the BEST it has been since we have started. #fyp #trt #testosterone
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about more frequent testosterone injections at lower per-dose amounts reduce peak-to-trough?
More frequent testosterone injections at lower per-dose amounts reduce peak-to-trough serum variability, which is the likely mechanism behind his symptom improvement, per Ramasamy et al. (2017, Journal of Urology).
What does the video say about 150mg of testosterone cypionate weekly?
150mg of testosterone cypionate weekly is within the range many providers use for hypogonadism, but the right dose is determined by labs and symptoms, not by copying someone else's protocol.
What does the video say about a 27-gauge needle has a narrower bore than a 25-gauge,?
A 27-gauge needle has a narrower bore than a 25-gauge, producing less tissue trauma and less injection pain. This is basic needle mechanics, not a trick.
What does the video say about a half-inch needle in the glute may deliver testosterone subcutaneously?
A half-inch needle in the glute may deliver testosterone subcutaneously rather than intramuscularly depending on body fat. Subcutaneous delivery is not inferior, but calling it IM may be inaccurate.
What does the video say about subcutaneous testosterone cypionate injections produce serum levels comparable to intramuscular?
Subcutaneous testosterone cypionate injections produce serum levels comparable to intramuscular delivery in hypogonadal men, per Spratt et al. (2021, Journal of the Endocrine Society).
What does the video say about the endocrine society guidelines (bhasin et al., 2018) recommend targeting?
The Endocrine Society guidelines (Bhasin et al., 2018) recommend targeting mid-normal physiologic testosterone, not peak levels. Supratherapeutic dosing raises estradiol and hematocrit risks.
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Pope | The Coach, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.